Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Feb;67(2):293–299.

Analysis of antigen involved in circulating immune complexes in patients with idiopathic thrombocytopenic purpura.

Y Kurata, S Hayashi, H Aochi, K Nagamine, M Oshida, H Mizutani, Y Tomiyama, T Tsubakio, T Yonezawa, S Tarui
PMCID: PMC1542597  PMID: 3608226

Abstract

Circulating immune complexes (CIC) were frequently observed in patients with idiopathic thrombocytopenic purpura (ITP). To analyse the pathogenic role of CIC, we studied the correlation between the disease activity and the CIC level, and whether platelet antigens were involved in CIC from ITP sera. Elevated CIC levels, measured by Clq, anti-C3 and spermatozoa micro-enzyme-linked immunosorbent assay, were found in 37%, 54% and 52% of the patients, respectively. However, there were no significant correlations (r = -0.11, -0.03 and -0.04, respectively) between the platelet count and the CIC level. Platelet antigens in CIC were detected with rabbit anti-human platelet serum. The CIC from 18%, 25% and 25%, respectively, of ITP sera contained platelet antigens, but the CIC from only 3%, 9% and 6% of SLE sera and from 3%, 2% and 5% of the sera of alloimmunized patients, respectively, contained these antigens. There were significant correlations (r = 0.51, 0.80 and 0.65, respectively) between the amount of platelet antigens and the CIC level in ITP sera. However, there were no correlations (r = -0.26, -0.29 and 0.08, respectively) between the platelet count and the amount of platelet antigens in the CIC. We detected platelet antigens in CIC from ITP sera, but surmise that these CIC perhaps do not play an important role in platelet destruction.

Full text

PDF
293

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campana D., Bergui L., Camussi G., Miniero R., Morgando M. P., Sardi A., Novarino A., Caligaris Cappio F. Immune-complexes and antiplatelet antibodies in idiopathic thrombocytopenic purpura. Haematologica. 1983 Mar-Apr;68(2):157–166. [PubMed] [Google Scholar]
  2. Clancy R., Trent R., Danis V., Davidson R. Autosensitization and immune complexes in chronic idiopathic thrombocytopenic purpura. Clin Exp Immunol. 1980 Jan;39(1):170–175. [PMC free article] [PubMed] [Google Scholar]
  3. Ercilla M. G., Borche L., Vives J., Castillo R., Gelabert A., Rozman C. Circulating immune complexes in immune thrombocytopenic purpura (ITP) Br J Haematol. 1982 Dec;52(4):679–680. doi: 10.1111/j.1365-2141.1982.tb03944.x. [DOI] [PubMed] [Google Scholar]
  4. Jordan S. C., Gautier E., Sakai R., Bahn L. Quantitation of circulating immune complexes in human serum by the Raji cell and F(ab')2 anti-C3 micro enzyme immunoassays. J Immunol Methods. 1985 Nov 7;83(2):363–370. doi: 10.1016/0022-1759(85)90258-3. [DOI] [PubMed] [Google Scholar]
  5. Kurata Y., Nishioeda Y., Tsubakio T., Kitani T. Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics. Acta Haematol. 1980;63(4):185–190. doi: 10.1159/000207396. [DOI] [PubMed] [Google Scholar]
  6. Lurhuma A. Z., Riccomi H., Masson P. L. The occurrence of circulating immune complexes and viral antigens in idiopathic thrombocytopenic purpura. Clin Exp Immunol. 1977 Apr;28(1):49–55. [PMC free article] [PubMed] [Google Scholar]
  7. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med. 1981 May 7;304(19):1135–1147. doi: 10.1056/NEJM198105073041904. [DOI] [PubMed] [Google Scholar]
  8. Migliorini P., Aiuti F., Balestrieri G., Bombardieri S., Cantarella S., Carbonara A., Clerici E., Coppo R., Cordiali Fei P., D'Amelio R. Comparison of pathologic and normal sera by immune complex determination: five disease groups within 190 samples are discriminated by computer-selected combinations of 13 methods. Report of the Italian committee for the study of immune complexes (WIC). Clin Immunol Immunopathol. 1984 Sep;32(3):298–315. doi: 10.1016/0090-1229(84)90274-5. [DOI] [PubMed] [Google Scholar]
  9. Singh V. K., Tingle A. J. Detection of circulating immune complexes by a C1q-microplate ELISA system. J Immunol Methods. 1982;50(1):109–114. doi: 10.1016/0022-1759(82)90308-8. [DOI] [PubMed] [Google Scholar]
  10. Trent R. J., Clancy R. L., Danis V., Basten A. Immune complexes in thrombocytopenic patients: cause or effect? Br J Haematol. 1980 Apr;44(4):645–654. doi: 10.1111/j.1365-2141.1980.tb08719.x. [DOI] [PubMed] [Google Scholar]
  11. Tsubakio T., Kurata Y., Kanayama Y., Yonezawa T., Tarui S., Kitani T. In vitro platelet phagocytosis in idiopathic thrombocytopenic purpura. Acta Haematol. 1983;70(4):250–256. doi: 10.1159/000206736. [DOI] [PubMed] [Google Scholar]
  12. Witkin S. S., Shahani S. K., Gupta S., Good R. A., Day N. K. Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum. Clin Exp Immunol. 1980 Sep;41(3):441–452. [PMC free article] [PubMed] [Google Scholar]
  13. Yonemasu K., Stroud R. M. Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies. J Immunol. 1971 Feb;106(2):304–313. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES